Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Evoke Pharma (EVOK) Change in Cash (2020 - 2025)

Historic Change in Cash for Evoke Pharma (EVOK) over the last 6 years, with Q3 2025 value amounting to -$483062.0.

  • Evoke Pharma's Change in Cash fell 12235.16% to -$483062.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $236978.0, marking a year-over-year decrease of 9559.05%. This contributed to the annual value of $8.9 million for FY2024, which is 27352.47% up from last year.
  • According to the latest figures from Q3 2025, Evoke Pharma's Change in Cash is -$483062.0, which was down 12235.16% from -$565018.0 recorded in Q2 2025.
  • In the past 5 years, Evoke Pharma's Change in Cash ranged from a high of $10.1 million in Q1 2021 and a low of -$5.6 million during Q3 2021
  • Its 5-year average for Change in Cash is $184582.7, with a median of -$1.0 million in 2023.
  • Data for Evoke Pharma's Change in Cash shows a peak YoY increase of 76096.55% (in 2021) and a maximum YoY decrease of 22630.95% (in 2021) over the last 5 years.
  • Evoke Pharma's Change in Cash (Quarter) stood at -$2.0 million in 2021, then dropped by 25.49% to -$2.5 million in 2022, then skyrocketed by 51.11% to -$1.2 million in 2023, then surged by 284.23% to $2.3 million in 2024, then crashed by 121.4% to -$483062.0 in 2025.
  • Its Change in Cash was -$483062.0 in Q3 2025, compared to -$565018.0 in Q2 2025 and -$972510.0 in Q1 2025.